Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Strongyloidiasis-related lung involvement: too much of a bad thing52
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era49
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel48
Editorial introductions44
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV43
La Crosse virus encephalitis in children42
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians41
From diagnosis to management: current perspectives on congenital cytomegalovirus infection35
Complexities of cardiomyopathy in septic shock33
Skin and soft tissue infections in the elderly32
Corticosteroids for viral central nervous system infections30
Surgical management of cystic echinococcosis of the liver29
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside29
Typhoid fever control in the 21st century: where are we now?28
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response28
Fusarium species central nervous system infection28
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?27
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients26
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management26
Managing cognitive impairment in people with HIV: Erratum26
Viral meningitis and encephalitis: an update25
Mycobacterial skin infection25
Mpox in people living with HIV24
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?24
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies22
Resistant herpes simplex virus infections – who, when, and what's new?22
Tuberculosis molecular bacterial load assay in the management of tuberculosis22
Malaria in pregnancy: baby steps21
Tick-borne encephalitis21
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach20
Editorial introductions20
Does climate change threaten delivery of HIV care in resource-limited settings?20
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention20
Using antibiotics wisely20
Interventions for polyoma virus-associated hemorrhagic cystitis18
Diagnostic approach and update on encephalitis18
Gut microbiome and its clinical implications: exploring the key players in human health17
CMV antiviral stewardship in transplantation – the next frontier17
Diagnostic stewardship: what impacts antibiotics use?17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis17
Haemophilus ducreyi in genital ulcer disease: new developments in an old disease16
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1916
Appropriate surgical management in skin and soft tissue infections16
The plumbing problem: rising antimicrobial resistance in building water systems15
Update on the treatment of chronic pulmonary aspergillosis15
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV15
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change14
Risk stratification for selecting empiric antibiotherapy during and after COVID-1914
The microbiota in respiratory tract infections: from association to intervention14
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles14
Editorial introductions14
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections14
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae13
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management13
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?13
Editorial: Pathogenesis and immune response – editorial13
Childhood tuberculosis13
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential13
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities13
An overview of risk factors, management and prevention of cochlear implant infections12
Interpreting and managing preservation fluids positive for Gram-negative bacteria12
Respiratory metagenomics: route to routine service12
Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics12
Data science for pediatric infectious disease: utilizing COVID-19 as a model12
The microbiome as a biomarker of anal precancerous lesions in people with HIV12
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients12
Update on drug treatments for multidrug resistant tuberculosis12
Travellers’ diarrhoea – solidifying our knowledgebase12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives11
Short-course antibiotic strategies for ventilator-associated pneumonia11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans11
Short treatment duration for community-acquired pneumonia11
Urinary tract infections in immunocompromised patients11
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis11
The disease burden of respiratory syncytial virus in Infants11
Skin and soft tissue infections in solid organ transplants10
Novel techniques in the treatment of skin and soft tissue infection10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities10
Burden of influenza in the elderly: a narrative review10
Neurobrucellosis10
Identifying patients with difficult-to-treat acute bacterial skin infections10
The evolution of knowledge for treating Gram-negative bacterial infections9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances9
A new era of HIV care for age-associated multimorbidity9
Therapeutic agents for the treatment of human mpox9
Chagas disease in the immunocompromised host9
Updates on the neurological manifestations of SARS-CoV-2 infection9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity9
Immune responses and severe dengue: what have we learned?9
Antibiotic treatment of acute bacterial skin and skin structure infections9
0.10997700691223